See also this year's filing and all EDGAR filings for this company.
PDF Report 0001131324_2013_Genomic_Health_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | No stock price available | subcommand.plot | {} |
| info | NetIncome node detected by tax heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001131324')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001131324, Genomic Health INC
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 0 |
| 1 | AssetsNonCurrent | 9,421,000 |
| 2 | AssetsCurrent | 130,209,000 |
| 3 | PropertyPlantAndEquipment | 14,104,000 |
| 4 | remainder_Assets | 0 |
| 5 | LongTermLiabilities | 0 |
| 6 | LiabilitiesCurrent | 25,340,000 |
| 7 | remainder_Liabilities | 0 |
| 8 | LaborExpense | 0 |
| 9 | CostOfGoodsAndServicesSold | 0 |
| 10 | GeneralAndAdministrativeExpense | 47,064,000 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 0 |
| 13 | DepreciationDepletionAndAmortization | 0 |
| 14 | SellingAndMarketingExpense | 93,553,000 |
| 15 | ResearchAndDevelopmentExpense | 49,104,000 |
| 16 | remainder_Expenses | 37,440,000 |
| 17 | remainder_Revenues | 235,173,000 |
| 18 | remainder_NetIncome | 237,000 |
| 19 | remainder_ComprehensiveNetIncome | 45,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 153,734,000 |
| 1 | Liabilities | 25,340,000 |
| 2 | Expenses | 227,161,000 |
| 3 | Revenues | 235,173,000 |
| 4 | StockholdersEquity | 128,394,000 |
| 5 | NetIncome | 8,249,000 |
| 6 | ComprehensiveNetIncome | 8,294,000 |
| 7 | BaseVar | 320,845,000 |
| 8 | EconomicCapitalRatio | 4.08 |
Edgar->Model Mapping
Feature Distribution
Change over Time
